Sponsor of the Day:
Jerkmate
https://www.sfb1709.de/
New Therapies for Myeloid Malignancies - SFB 1709
Apr 17, 2026 - Discover groundbreaking insights on Cellular Plasticity in Myeloid Malignancies and new therapies aimed at overcoming cancer resistance.
new therapiesmyeloid malignanciessfb1709
https://www.kidney.org/news-stories/what-you-should-know-about-complement-3-glomerulopathy-c3g?page=1
Rare Kidney Disease C3G: Types, Diagnosis, and New Therapies | National Kidney Foundation
C3G is a rare kidney disease with new treatments emerging. Learn the signs, types, therapies, and how research is driving hope for patients.
rare kidney diseasetypes diagnosisnew therapiesnational foundationc3g
https://news.cornell.edu/stories/2025/01/bacterial-changes-point-new-therapies-legionnaires-disease
Bacterial changes point to new therapies for Legionnaires’ disease | Cornell Chronicle
Researchers have pinpointed a key enzyme that allows Legionella to persist in the environment and in the body - and which could be used as a target for...
new therapiescornell chroniclebacterialchangespoint
https://stanmed.stanford.edu/innovations-returning-sight-glaucoma-patients/
New therapies show promise for restoring glaucoma patients’ vision
Apr 22, 2026 - Ophthalmologists are testing eye implants, growth factors and gene therapy to protect optic nerves and slow glaucoma-related vision loss.
new therapiesshow promiserestoringglaucomavision
https://www.broadinstitute.org/how-broad-scientists-are-bridging-gap-between-biological-insights-and-new-therapies
How Broad scientists are bridging the gap between biological insights and new therapies | Broad...
At Broad’s Center for the Development of Therapeutics, biologists collaborate with drug-development experts to bring novel therapies to the clinic.
biological insightsnew therapiesbroadscientistsbridging
https://news.cornell.edu/stories/2026/04/discovery-could-lead-new-therapies-blood-disorders
Discovery could lead to new therapies for blood disorders | Cornell Chronicle
Weill Cornell Medicine investigators have revealed the detailed workings of a cell membrane protein; the discovery could lead to new therapies for blood...
discovery could leadnew therapiesblood disorderscornell chronicle
https://pharmaphorum.com/patients/providing-patient-access-new-therapies-dean-erhardt
Providing patient access to new therapies, with Dean Erhardt | pharmaphorum
Dean Erhardt, founder of D2 Solutions, discusses patient access today versus the state of patient access tomorrow.
patient accessnew therapiesprovidingdeanerhardt